Sagit Manor Sells Shares of NYAX

Sagit Manor, the Chief Financial Officer of NYAX, sold 214 shares of the company on June 29, 2026. The transaction was valued at approximately $13,666, with the shares sold at an average price of $63.86 each. This sale was not part of a pre-planned trading program.

Other Institutional Activity in NYAX

Institutional investors have made notable changes to their positions in NYAX. Y.D. More Investments Ltd increased its holdings by 25,694 shares, now holding 865,171 shares valued at about $48.39 million, marking a 3.1% increase. Capital World Investors, on the other hand, reduced its stake by 84,259 shares, bringing its total to 715,793 shares worth approximately $40.46 million, a decrease of 10.5%. AltraVue Capital, LLC significantly boosted its position by 319,861 shares, up 139.2%, to a total of 549,574 shares valued at $30.78 million. Vanguard Capital Management LLC opened a new position with 410,361 shares, valued at $23.14 million. Meanwhile, Clal Insurance Enterprises Holdings Ltd cut its holdings by 275,355 shares, a 41.7% reduction, to 384,524 shares valued at $21.53 million.

Nayax Ltd. Stock Up 25.5%

Shares of NYAX traded near $64.07 on Tuesday. The stock has seen a 52-week low of $52.00 and a high of $75.00. Its 50-day moving average is $63.00, while the 200-day moving average stands at $60.00. NYAX's recent trading activity reflects a stable performance, with a focus on institutional interest and insider transactions.

Insider Buying and Selling at Nayax Ltd.

In addition to Sagit Manor's recent sale, other insiders also sold shares on June 29, 2026. Aaron Samuel Greenberg, the Chief Strategy Officer, sold 54 shares at $63.85. Oren Tepper, Chief Revenue Officer, sold 74 shares at $63.80 and another 57 shares on June 26, 2026, at $64.02. Michal Sever, Chief Marketing Officer, sold 35 shares at $63.89. Carly Lisanne Furman, CEO of NAYX North America, sold 109 shares at $64.42.

Analysts Set New Price Targets

Analyst firms have maintained their ratings for NYAX. On June 24, 2026, UBS maintained a 'hold' rating with a price target of $75. Previously, UBS had set a target of $68 on May 13, 2026. Keefe, Bruyette & Woods also maintained a 'hold' rating with a $75 target on May 13, 2026. The consensus among analysts remains a 'hold', with an average target price reflecting cautious optimism.

Bottom Line

The recent insider sales at NYAX, including those by CFO Sagit Manor, are part of ongoing trading activities by company insiders. Institutional investors are also actively adjusting their positions, reflecting varying levels of confidence in the company's future performance. While insider transactions are not uncommon, they can provide insights into the company's internal sentiment. Analyst ratings continue to suggest a 'hold' stance, indicating a balanced view of NYAX's prospects.